No menu items!

Tag: reduces the relative risk of Covid-19 by up to 70%

RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (ANVISA) on Thursday, May 13, unanimously approved the use of two drugs, the monoclonal antibodies banlanivimab and etesevimab, for the treatment of coronavirus patients in the country. The decision was...

LATEST NEWS

WEATHER

Rio de Janeiro
heavy intensity rain
26 ° C
29 °
26 °
77 %
8.8kmh
75 %
Wed
26 °
Thu
30 °
Fri
29 °
Sat
29 °
Sun
30 °